On-Body Drug Delivery Systems (OBDS) are transforming how medications are administered, offering innovative solutions for high-volume and viscous drug formulations where traditional autoinjectors often fall short. These systems combine advanced engineering with patient-centric design to improve treatment outcomes and adherence.
This webinar will explore the limitations of current drug delivery methods, focusing on challenges such as volume constraints, patient comfort, and adherence. Using the Sorrel OBDS platform as a case study, we will highlight its role in the development of the UDENYCA On-body injector, which has redefined delivery efficiency by significantly reducing administration times while maintaining usability and comfort.
Gain insights into the steps required to transition OBDS platforms from prototypes to clinical readiness, ensuring devices are optimised for both patient needs and regulatory requirements.
This session is ideal for professionals looking to deepen their understanding of OBDS technologies and their impact on the future of drug delivery.
<span>By ticking this box, you consent to receiving communications from LTS related to this topic and other products or services within their portfolio</span>